ArticleJournal of oral and maxillofacial pathology : JOMFP
Analysis of local aggressiveness and malignancy transformation potential of ameloblastoma through osteopontin and CD10 expression (Immunohistochemical research).
Article in Journal of oral and maxillofacial pathology : JOMFP. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Ameloblastoma is a benign, slow-growing odontogenic neoplasia that can infiltrate soft tissue and penetrate bone. Molecular markers like IHC staining with Osteopontin and CD10 antibodies can help understand the abnormalities and predict malignant transformation. This study aims to improve diagnosis and treatment by tracking these indicators alongside other clinicopathological aspects. Material and Methods: The study analyzed the correlation between OPN and CD10 expression and ameloblastoma aggressiveness and malignant transformation using 35 paraffin blocks. IHC staining was performed using OPN and CD10 markers, and cell counts and staining intensities were calculated using the IRS method. The IRS score was correlated with clinicopathological parameters using statistical tests ( Results: The results of the OPN expression examination are strong (37.2%), moderate (37.2%), weak (17.1%), and negative (8.5%) Meanwhile, the results of the CD10 expression examination are moderate (28.6%), weak (54.2%), and negative (17.2%). Correlation test for OPN and CD10 expression is Conclusions: Ameloblastoma aggressiveness is indicated by high OPN and CD10 expression, while malignancy transformation potential is indicated by high OPN and low CD10 expression, with CD10 expression correlated with tumor size.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.